Pacific Biosciences of California, Inc. (PACB) Stock
NSQ · PACB
1.36
Fundamentals
Market cap
$425.84M
Price / Earnings ratio
-3.2x
Price / Sales ratio
2.7x
Price / Book ratio
-12.8x
Return on assets
-0.2%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A
Latest news
About Pacific Biosciences of California, Inc.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.
SectorHealthcare
IndustryMedical Devices
Employees485
CEOMr. Mark Van Oene Ph.D.
IPO DateOct 27, 2010
HeadquartersMenlo Park, CA
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Mark Van Oene Ph.D. | CEO, President & Director | 1973 |
| Mr. James R. Gibson II | CFO & Principal Accounting Officer | 1970 |
| Mr. Christian O. Henry M.B.A. | Senior Business Advisor & Director | 1968 |
| Dr. Stephen Turner Ph.D. | Co-Founder | 1968 |
| Dr. Brett Atkins J.D., Ph.D. | General Counsel & Corporate Secretary | — |
| Ms. Natalie Welch | Chief People Officer | — |
Fundamentals
Valuation
Market cap$425.84M
Price-to-sales ratio2.67
Price-to-book value-12.82
Price-earnings ratio-3.20
Return on Equity-488.00%
Return on SalesN/A
Return on AssetsN/A
PEG ratio-0.17
Earnings Per Share
Earnings Per Share$-0.43
Income Statement
Average volume5,894,181
EBITDA$-103.11M
1 year high (52w)$2.73
1 year low (52w)$1.07
Dividend
Ex dividend dateN/A
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



